Company Profile
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2024, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
At the end of 2024, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.
Source: Cofisem - Last Update: 2025-09-03
Key Executives
| Chief Executive Officer | |
| Chief Financial Officer | |
| Chief Commercial Officer | |
| Chief Communication Officer | |
| Head of Investor Relations | |
| Director of Sustainable Development | |
| Chief Human Resources Officer |
Source: Cofisem - Last Update: 2025-09-03
Key Figures
| Millenium | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Net sales | 1,185,427 | 1,148,210 | 1,361,138 | 1,237,654 | 881,305 |
| Income from ordinary activities | 1,185,427 | 1,148,210 | 1,361,138 | 1,237,654 | 881,305 |
| Operating income | 258,325 | 216,261 | 351,260 | 419,499 | 324,226 |
| Cost of financial indebtedness net | 27,555 | 28,291 | 34,072 | 22,506 | 1,375 |
| Equity-accounted companies contribution to income | |||||
| Net profit from discontinued activities | |||||
| Net income | 187,057 | 158,508 | 240,110 | 310,732 | 248,296 |
| Net income (Group share) | 188,105 | 159,849 | 240,907 | 310,968 | 247,871 |
| Fiscal year end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
Source: Cofisem - Last Update: 2025-09-03
Shareholder information
| Finde SS | |
| Other shareholders | |
| Carlo Rosa | |
| Chen Menachem Even | |
| T. Rowe Price Associates, Inc. |
Source: Cofisem - Last Update: 2025-09-03
Address
DiaSorin S.p.A.
Via Crescentino snc
IT-13040 Saluggia
Italy
Phone number: +39 (0)161487526
Fax: +39 (0)16147670
https://diasoringroup.com/
Source: Cofisem - Last Update: 2025-09-03
Contact
Please contact MyQuestion.Italy@euronext.com for Company Profile support.